Stock Analysis
Recordati Industria Chimica e Farmaceutica Third Quarter 2023 Earnings: EPS: €0.37 (vs €0.44 in 3Q 2022)
Recordati Industria Chimica e Farmaceutica (BIT:REC) Third Quarter 2023 Results
Key Financial Results
- Revenue: €511.9m (up 5.5% from 3Q 2022).
- Net income: €76.9m (down 15% from 3Q 2022).
- Profit margin: 15% (down from 19% in 3Q 2022). The decrease in margin was driven by higher expenses.
- EPS: €0.37 (down from €0.44 in 3Q 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Recordati Industria Chimica e Farmaceutica Earnings Insights
Looking ahead, revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 7.3% growth forecast for the Pharmaceuticals industry in Europe.
Performance of the market in Italy.
The company's shares are up 1.8% from a week ago.
Risk Analysis
We should say that we've discovered 2 warning signs for Recordati Industria Chimica e Farmaceutica that you should be aware of before investing here.
Valuation is complex, but we're helping make it simple.
Find out whether Recordati Industria Chimica e Farmaceutica is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About BIT:REC
Recordati Industria Chimica e Farmaceutica
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide.
Solid track record with reasonable growth potential and pays a dividend.